The BRAIN App for Dementia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The Hearthstone Institute, Winchester, MA
Dementia+3 More
The BRAIN App - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study will involve testing of an Alpha version of an app called "Building Relationships using Artificial Intelligence and Nostalgia" or BRAIN. The BRAIN App will be the first -ever artificial intelligence infused CST app for PWD. The app has two main goals: (1) to foster positive relationships between the care triad, and (2) to promote QoL while reducing responsive behaviors in PWD. Testing will examine the app's impact on engagement/affect for both PWD and professional Care Partners.

Eligible Conditions

  • Dementia
  • Dementia, Vascular
  • Alzheimer Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Treatment--that is, week 5 thru week 8

Week 5
Dementia Related Quality of Life (DEMQOL)
Neuropsychiatric Inventory--Nursing Home (NPI-NH)
Quality of Carer-Patient Relationship (QCPR)
Week 8
Engagement for Persons with Dementia Scale (EPWDS)
Menorah Park Engagement Scale (MPES)

Trial Safety

Trial Design

1 Treatment Group

Treatment
1 of 1
Experimental Treatment

68 Total Participants · 1 Treatment Group

Primary Treatment: The BRAIN App · No Placebo Group · N/A

Treatment
Behavioral
Experimental Group · 1 Intervention: The BRAIN App · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: treatment--that is, week 5 thru week 8
Closest Location: The Hearthstone Institute · Winchester, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
N/AFirst Recorded Clinical Trial
2 TrialsResearching Dementia
0 CompletedClinical Trials

Who is running the clinical trial?

The Hearthstone Institute, LLCLead Sponsor
3 Previous Clinical Trials
297 Total Patients Enrolled
3 Trials studying Dementia
297 Patients Enrolled for Dementia
Michael Skrajner, MAPrincipal InvestigatorThe Hearthstone Institute
3 Previous Clinical Trials
297 Total Patients Enrolled
3 Trials studying Dementia
297 Patients Enrolled for Dementia

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be able to read and speak English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.